Light therapy for knee bleeding in hemophilia children
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital clinical trials.
This study tests whether a special type of light therapy (photobiomodulation) can help reduce pain and swelling in the knees of children with hemophilia who experience bleeding into the joint. Hemophilia is a bleeding disorder where blood doesn't clot properly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hemophilia and have experienced bleeding into your knee joint
- You are between 9 and 14 years old
- You have no open wounds or cuts at or near your knee
- Your knee joint is properly aligned (not dislocated or out of place)
- You have no major bone shape differences or skeletal abnormalities
- You do not have heart, lung, or nervous system conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of strength training can improve knee function in boys with hemophilia who have had bleeding in one knee. It may help them walk and move better.
This trial studies whether a structured exercise program helps children with hemophilia A or B safely. It looks at children’s ability to exercise and function, while aiming to avoid complications like leg bleeds or injuries.
This trial tests whether an educational program can help patients with hemophilia-related joint damage manage chronic pain better. If you have hemophilia A or B, painful joints, and want to learn new pain coping skills, this study may be a good fit.
This study uses MRI scans to look at knee joint damage caused by repeated bleeding in people with hemophilia. It may help doctors understand joint changes and guide treatment.
This trial tests whether a special type of exercise that limits blood flow is safe and possible for people with hemophilia. It might help strengthen muscles without causing joint bleeds.
This trial uses ultrasound to check if healthy joints in people with hemophilia A develop damage while being treated with emicizumab (Hemlibra). It looks at elbows, knees, and ankles over time to see if the medicine prevents joint problems.
Hear when a new Hemarthrosis, Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.